In mice exposed to mitochondrial Complex I inhibitor (MPTP) to model PD, the loss of tyrosine hydroxylase and dopamine was partially negated with K4R SHLP2 pretreatment [63]. Here, MT-RNR2 is linked to Parkinson disease.